We are live on
!
Find out more
AL
Aspiriant LLC Portfolio holdings
AUM
$4.05B
1-Year Est. Return
19.01%
This Fund
S&P 500
This Quarter
Est. Return
-5.53%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$2.04B
AUM Growth
-$27.8M
(-1.3%)
Cap. Flow
+$98.2M
Cap. Flow
% of AUM
4.8%
Top 10 Holdings %
Top 10 Hldgs %
60.58%
Holding
282
New
8
Increased
111
Reduced
95
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
+$42.4M |
| 2 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$26.1M |
| 3 |
iShares MSCI EAFE Min Vol Factor ETF
EFAV
|
+$25.2M |
| 4 |
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
|
+$21.6M |
| 5 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$19.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$42.6M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$13.2M |
| 3 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$5.65M |
| 4 |
Fidelity Total Bond ETF
FBND
|
+$3.81M |
| 5 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$3.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.23% |
| 2 | Financials | 2.11% |
| 3 | Communication Services | 1.1% |
| 4 | Healthcare | 0.95% |
| 5 | Consumer Discretionary | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.91B
| – | – |
-3,446
| Closed | -$299K |
|
277
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
| – | – |
-8,133
| Closed | -$358K |
|
|
SLNO
278
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-3,820
| Closed | -$11K |
|
279
Vanguard FTSE Europe ETF
VGK
$30.1B
| – | – |
-4,670
| Closed | -$247K |
|
280
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.14B
| – | – |
-4,154
| Closed | -$255K |
|
281
Vanguard International High Dividend Yield ETF
VYMI
$20.3B
| – | – |
-5,108
| Closed | -$300K |
|
|
PRVB
282
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| – | – |
-11,000
| Closed | -$44K |
|
Similar funds
ICP
BWA
CA
JSW
MGP
AI
BHC
MAM
Aspiriant LLC's Q3 2022 Portfolio in Review
As of Q3 2022, Aspiriant LLC held 282 positions worth $2.04B, down 1.3% from $2.07B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Aspiriant LLC deployed $98.2M of net new capital in Q3 2022, opening 8 new positions and adding to 111 existing holdings. Its largest new stake was Cincinnati Financial: 42,492 shares worth $3.81M.
By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 4.9% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $42.6M trimmed.
- Aspiriant LLC's largest Q3 2022 buy was Cincinnati Financial: 42,492 shares worth $3.81M.
- Aspiriant LLC added most to Vanguard Dividend Appreciation ETF in Q3 2022, an estimated $42.4M increase.
- Aspiriant LLC's biggest Q3 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $42.6M.
- Aspiriant LLC fully exited iShares ESG Aware MSCI USA ETF in Q3 2022, selling an estimated $1.23M.
- Aspiriant LLC's ten largest holdings make up 61% of its $2.04B portfolio in Q3 2022.
- Aspiriant LLC opened 8 new positions and closed 20 in Q3 2022.
- Aspiriant LLC's portfolio value fell 1.3% quarter-over-quarter to $2.04B.
Based on Aspiriant LLC's 13F filing for Q3 2022, filed 28 Oct 2022.